Advertisement

Topics

Sofinnova Partners Company Profile

07:11 EDT 24th June 2018 | BioPortfolio

1972 Sofinnova is the first venture capital company created in France.Sofinnova Partners is an independent venture capital company based in Paris. We have special relations with Sofinnova Ventures, our sister firm based in San Francisco. We invest primarily in companies in information technologies and life sciences, in France and in other European countries. A limited portion of our investments is made in the US.Sofinnova’s team usually invests as lead or co-lead investor in first and second rounds in collaboration with leading European, US and Asian venture capital funds, especially in the UK, Switzerland, Germany, Scandinavia, Belgium and Luxembourg.In Information Technology, Sofinnova Partners aims to identify new trends and technological breakthroughs in areas including: Materials, photonics and micro-electronics Embedded software and user interfaces for wireless and consumer electronics IT infrastructure software solutions

Location

17, rue de Surène
Paris
75008
France

Contact

Phone: 33 (0)1 5305-4100
Fax: 33 (0)1 5305-4129
Email: deal@sofinnova.fr


News Articles [241 Associated News Articles listed on BioPortfolio]

$340M life sciences crossover fund launched by Sofinnova Partners

The life sciences-focused Sofinnova Crossover Fund I was launched by Paris-based venture capital firm Sofinnova Partners afte -More- 

Sofinnova crosses over

Sofinnova Partners raised its first crossover fund to attract international investors to late-stage EU biotechs.

Antoine Papiernik, Managing Partner: How Sofinnova Partners achieve high returns through taking calculated risks.

Sofinnova invest early in projects with disruptive technologies that have the potential to become strong sustainable companies with the potential to return in excess of 10x their investment. Antoine P...

French Crossover Fund Raises €275M to Invest in Medical Biotechs

Sofinnova Partners has launched a crossover fund focusing on European companies to support medical biotechs across all funding stages, from seed to late stage.  Sofinnova Partners, the largest French...

Neurana brings in $60mm Series A round

CNS-focused Neurana Pharmaceuticals Inc. (formerly Katama) closed a $60mm Series A round led by Sofinnova Ventures. New Leaf Venture Partners, HIG BioHealth Partners, Longitude Capital, and MagnaSci V...

French VC Raises the Biggest Green Biotech Fund in Europe

Update (15/03/2018): Sofinnova Partners has closed its fund Industrial Biotech I at €125M, making it the largest European fund dedicated to driving the transition towards a more sustainable fund. 03...

French VC Raises the Biggest Green Biotech Fund in the World

Update (15/03/2018): Sofinnova Partners has closed its fund Industrial Biotech I at €125M, making it the largest fund dedicated to driving the transition towards a more sustainable fund. 03/03/2017 ...

Sofinnova Targets Later Stage Firms With €275M Healthcare Crossover Fund

After four decades of exclusively backing early stage life science start-ups, French venture capitalist Sofinnova Partners has launched its first...   

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [251 Associated PubMed Articles listed on BioPortfolio]

Evaluating a psychosocial intervention for men with prostate cancer and their partners: Outcomes and lessons learned from a randomized controlled trial.

This study evaluated the process and outcome of a psychosocial intervention for men with prostate cancer and their partners. As more men survive prostate cancer, they and their partners need help and ...

What Does it Need to Improve Nutrition Quality? The Role of Public Partners.

Public partners play a key role when we want to improve nutrition quality. They will not succeed, when they try to achieve the goal alone or tend to dominate other players. In their responsibility for...

How Patient Partners Influence Quality Improvement Efforts.

There is growing acknowledgement that patients are key stakeholders in improving quality of medical care, yet a key barrier to integrating patients into quality improvement teams (QITs) as patient par...

The Hidden Roles That Management Partners Play In Accountable Care Organizations.

Accountable care organizations (ACOs) are often discussed and promoted as driven by physicians, hospitals, and other health care providers. However, because of the flexible nature of ACO contracts, ma...

Quality of Life in Partners of Young and Old Breast Cancer Survivors.

Partners of breast cancer survivors experience the effects of a spouse's cancer years after treatment. Partners of younger survivors (YPs) may experience greater problems than partners of older surviv...

Clinical Trials [291 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

Companies [933 Associated Companies listed on BioPortfolio]

Sofinnova Partners

1972 Sofinnova is the first venture capital company created in France.Sofinnova Partners is an independent venture capital company based in Paris. We have special relations with Sofinnova Ventures, o...

Marinus Pharmaceuticals, Inc.

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. Marinus ...

Sofinnova Ventures

Sofinnova Ventures we are company builders who work with our entrepreneurs as a team. Our firm, based in San Francisco and founded in 1974, invests venture capital in early-stage Life Science and Info...

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide...

HighLife SAS and Sofinnova Partners

HighLife SAS, headquartered in Paris, with offices in Irvine, Calif., is an early-stage company established in 2010. It is focused on the development of a novel transcatheter repl...

More Information about "Sofinnova Partners" on BioPortfolio

We have published hundreds of Sofinnova Partners news stories on BioPortfolio along with dozens of Sofinnova Partners Clinical Trials and PubMed Articles about Sofinnova Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sofinnova Partners Companies in our database. You can also find out about relevant Sofinnova Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record